DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
Federal NHANES data show that only about 1 in 20 Americans are at risk of true vitamin D deficiency, but the burden falls unevenly: non-Hispanic Black adults are at risk at roughly 8 times the rate of non-Hispanic white adults.
Most Americans have adequate vitamin D, but the risk of true deficiency is concentrated sharply by race, age, body weight, and supplement use. According to the CDC's National Health and Nutrition Examination Survey (NHANES) for 2011–2014, about 5.0% of people aged 1 and older were at risk of vitamin D deficiency and another 18.3% were at risk of inadequacy — meaning roughly 1 in 4 Americans fell below recommended blood levels, while about three-quarters were in the sufficient range.
The gap between groups is the real story. Non-Hispanic Black Americans were at risk of deficiency at a rate of 17.5%, compared with just 2.1% of non-Hispanic white Americans — a more than eightfold difference. (These are population risk categories from a single blood draw, not individual diagnoses.)
This article is informational and educational. It describes population-level patterns in public-health data; it does not diagnose any condition or provide medical advice. Decisions about vitamin D testing or supplementation should be made with a qualified clinician.
Vitamin D status is measured by serum 25-hydroxyvitamin D [25(OH)D], the standard blood marker. The CDC's National Center for Health Statistics classifies status using these cut points:
These thresholds matter because prevalence figures swing widely depending on which one a study uses. Under a looser definition — counting everyone below 50 nmol/L — a pooled NHANES analysis covering 2001–2018 found about 2.6% with severe deficiency (<25 nmol/L) and 22.0% with moderate deficiency (25–50 nmol/L). So context determines whether the 'deficient' share looks closer to 5% or closer to 25%.
The disparity by race and ethnicity is the most consistent finding across decades of NHANES data. In 2011–2014, the share at risk of deficiency was:
The same ordering holds for the broader 'at risk of inadequacy' category, where 35.8% of non-Hispanic Black Americans fell short versus 11.8% of non-Hispanic white Americans.
The pooled 2001–2018 analysis, using a stricter severe-deficiency threshold (<25 nmol/L), found an even starker gap: 11.9% of non-Hispanic Black Americans versus 0.9% of non-Hispanic white Americans.
What it means: Higher skin melanin reduces the skin's vitamin D synthesis from sunlight, which is one biological driver of this pattern. Behavior compounds biology — supplement use is far lower in the groups with the highest deficiency risk. In 2011–2014, 43.7% of non-Hispanic white adults reported vitamin D supplement use, versus 24.8% of non-Hispanic Black and 22.0% of Hispanic adults. NHANES is observational, so these are associations, not proof of cause.
Contrary to the common assumption that older people are most vulnerable, NHANES shows the risk of deficiency peaks in young adulthood. In 2011–2014, the share at risk of deficiency by age was:
The 2001–2018 pooled data agree, locating peak deficiency in the 20–29 age band. Lower deficiency among older adults likely reflects higher supplement and fortified-food use rather than better sun-driven synthesis, which actually declines with age.
Sex: Women carry a modestly higher burden. In 2011–2014, 5.7% of females were at risk of deficiency versus 4.4% of males. The longer 2001–2018 series shows the same pattern for severe deficiency (3.1% of women vs. 2.1% of men).
Season: Sunlight exposure drives a large seasonal swing. In the 2001–2018 data, severe deficiency was 4.1% in winter versus 1.6% in summer, and moderate deficiency was 28.9% in winter versus 17.0% in summer.
Body weight: Obesity is associated with low vitamin D. In NHANES 2011–2012, 42.5% of vitamin D–deficient adults were obese (BMI ≥30) versus 31.1% of sufficient adults (adjusted odds ratio 1.31; 95% CI 1.15–1.49). Vitamin D is fat-soluble and is thought to be sequestered in adipose tissue, which can lower circulating levels.
The clearest behavioral signal in the data is supplementation. Among people reporting vitamin D supplement use in 2011–2014, only 1.1% were at risk of deficiency — versus 6.9% among non-users. Because the survey is observational, this reflects a strong association rather than a guaranteed cause-and-effect. The NIH Office of Dietary Supplements sets the Recommended Dietary Allowance at 600 IU (15 mcg) daily for most people aged 1–70 and 800 IU (20 mcg) for adults over 70, with an Adequate Intake of 400 IU (10 mcg) for infants. Individual needs vary, and high-dose supplementation should be guided by a clinician.
The longer-term picture is cautiously encouraging. After deficiency risk rose between NHANES III (1988–1994) and the early 2000s — the age- and season-adjusted share at risk of deficiency climbed from 3% to 7% in males and from 7% to 11% in females, per CDC — the 2001–2018 series shows moderate deficiency edging down and sufficiency edging up. The reported changes are statistically significant but small, and severe deficiency showed no significant change.
NHANES is cross-sectional, so it shows associations, not causation. A single blood draw captures a moment in time and cannot reflect an individual's seasonal variation. Comparing studies is tricky because deficiency thresholds differ, and assay methods have been recalibrated over time, complicating long-run trends. Self-reported supplement use and diet are subject to recall error. The 'at risk' categories are population classifications, not clinical diagnoses. None of these figures should be read as medical advice; testing and treatment decisions belong with a healthcare provider.
% of U.S. population at risk of vitamin D deficiency / inadequacy (NHANES 2011-2014)
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | Race / Hispanic origin | Non-Hispanic Black | 17.5 | 15.2-20.0 | 35.8 | 33.3-38.5 |
| 2 | Age | 20-39 years | 7.6 | 6.0-9.6 | 23.8 | 20.9-27.0 |
| 3 | Race / Hispanic origin | Non-Hispanic Asian | 7.6 | 5.9-9.9 | 29.1 | 26.4-32.0 |
| 4 | Race / Hispanic origin | Hispanic | 5.9 | 4.4-7.8 | 26.3 | 23.0-29.8 |
| 5 | Sex | Female | 5.7 | 4.5-7.0 | 17.8 | 15.8-20.1 |
| 6 | Age | 40-59 years | 5.7 | 4.6-7.0 | 18.6 | 15.9-21.6 |
| 7 | Total (>=1 year) | All | 5 | 4.1-6.2 | 18.3 | 16.2-20.6 |
| 8 | Age | 12-19 years | 4.8 | 3.5-6.4 | 22.7 | 19.3-26.4 |
| 9 | Sex | Male | 4.4 | 3.5-5.5 | 18.7 | 16.3-21.4 |
| 10 | Age | >=60 years | 2.9 | 2.0-4.0 | 12.3 | 10.7-14.1 |
Source: Herrick KA et al., 'Vitamin D status in the United States, 2011-2014,' Am J Clin Nutr 2019 (NHANES 2011-2014; NCHS/CDC). https://pmc.ncbi.nlm.nih.gov/articles/PMC7263437/. Vitamin D status = serum 25-hydroxyvitamin D. 'At risk of deficiency' = <30 nmol/L; 'at risk of inadequacy' = 30-49 nmol/L. Values (and 95% CIs) copied exactly from the published source; persons aged >=1 year.
Sourced the authoritative NCHS/CDC analysis of NHANES 2011-2014 serum 25(OH)D published in the American Journal of Clinical Nutrition (2019). Fetched the PubMed Central full text and transcribed the exact prevalence percentages and 95% confidence intervals by demographic group (total, sex, age group, race/Hispanic origin). Cross-verified every overall, age, and race/ethnicity figure against the PubMed abstract; all values matched exactly. No numbers were estimated or interpolated. Two metrics per group: "at risk of deficiency" (<30 nmol/L) and "at risk of inadequacy" (30-49 nmol/L).
Data source: Herrick KA, Storandt RJ, Afful J, et al. "Vitamin D status in the United States, 2011–2014." American Journal of Clinical Nutrition (AJCN), 2019;110(1):150–157 (NHANES 2011–2014; NCHS/CDC). Values transcribed from the full text via PubMed Central: https://pmc.ncbi.nlm.nih.gov/articles/PMC7263437/ (abstract corroborated at https://pubmed.ncbi.nlm.nih.gov/31076739/). Vitamin D status measured as serum 25-hydroxyvitamin D [25(OH)D]; "at risk of deficiency" = <30 nmol/L, "at risk of inadequacy" = 30–49 nmol/L.
Fair use: journalists, educators, and researchers are welcome to reference the data and visuals from this study in any medium. We only ask that you credit HealthVetted with a link back to this page so readers can see the full methodology.
HealthVetted. (2026). Vitamin D Insufficiency Across US Demographics. HealthVetted. https://healthvetted.com/research/vitamin-d-insufficiency-demographics
"Vitamin D Insufficiency Across US Demographics." HealthVetted, 2026, https://healthvetted.com/research/vitamin-d-insufficiency-demographics.
<p>Source: <a href="https://healthvetted.com/research/vitamin-d-insufficiency-demographics">Vitamin D Insufficiency Across US Demographics</a> by <a href="https://healthvetted.com">HealthVetted</a>.</p>
<iframe src="https://healthvetted.com/embed/study/vitamin-d-insufficiency-demographics" width="540" height="420" style="border:1px solid #e5e7eb;border-radius:12px;max-width:100%" loading="lazy" title="Vitamin D Insufficiency Across US Demographics — HealthVetted"></iframe>